In April of 2022, a MIT feasibility grant was made available to further explore market opportunities for the implementation of tests for STI’s.

Rapidemic has been awarded the €20 000 grant by the RVO and the province Zuid-Holland to continue their market research for their first product. The grant will fund the research on market opportunities in the field of diagnostics of sexually transmitted infections in The Netherlands, and in Europe. We are grateful for this support form RVO and Provincie Zuid-Holland.